nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—EGFR—type 1 diabetes mellitus	0.702	1	CbGaD
Afatinib—BLK—lymphoid tissue—type 1 diabetes mellitus	0.00274	0.078	CbGeAlD
Afatinib—Vandetanib—ERBB3—type 1 diabetes mellitus	0.00272	0.322	CrCbGaD
Afatinib—Gefitinib—ERBB3—type 1 diabetes mellitus	0.00258	0.306	CrCbGaD
Afatinib—IRAK1—islet of Langerhans—type 1 diabetes mellitus	0.00231	0.0658	CbGeAlD
Afatinib—ERBB2—cardiovascular system—type 1 diabetes mellitus	0.00224	0.0636	CbGeAlD
Afatinib—ERBB4—cardiovascular system—type 1 diabetes mellitus	0.00224	0.0636	CbGeAlD
Afatinib—ERBB2—kidney—type 1 diabetes mellitus	0.00219	0.0622	CbGeAlD
Afatinib—ERBB2—pancreas—type 1 diabetes mellitus	0.00217	0.0618	CbGeAlD
Afatinib—DYRK1A—cardiovascular system—type 1 diabetes mellitus	0.00215	0.0612	CbGeAlD
Afatinib—DYRK1A—kidney—type 1 diabetes mellitus	0.00211	0.0599	CbGeAlD
Afatinib—ERBB2—lymphoid tissue—type 1 diabetes mellitus	0.00188	0.0535	CbGeAlD
Afatinib—IRAK1—nephron tubule—type 1 diabetes mellitus	0.00186	0.053	CbGeAlD
Afatinib—DYRK1A—lymphoid tissue—type 1 diabetes mellitus	0.00181	0.0515	CbGeAlD
Afatinib—IRAK1—pancreas—type 1 diabetes mellitus	0.00163	0.0462	CbGeAlD
Afatinib—ABL1—islet of Langerhans—type 1 diabetes mellitus	0.0013	0.0368	CbGeAlD
Afatinib—Vandetanib—EGFR—type 1 diabetes mellitus	0.00122	0.145	CrCbGaD
Afatinib—Gefitinib—EGFR—type 1 diabetes mellitus	0.00116	0.137	CrCbGaD
Afatinib—ABL1—retina—type 1 diabetes mellitus	0.00111	0.0315	CbGeAlD
Afatinib—ABL1—nephron tubule—type 1 diabetes mellitus	0.00104	0.0297	CbGeAlD
Afatinib—ABL1—cardiovascular system—type 1 diabetes mellitus	0.000937	0.0266	CbGeAlD
Afatinib—ABL1—kidney—type 1 diabetes mellitus	0.000917	0.0261	CbGeAlD
Afatinib—ABL1—pancreas—type 1 diabetes mellitus	0.000911	0.0259	CbGeAlD
Afatinib—ABL1—lymphoid tissue—type 1 diabetes mellitus	0.000788	0.0224	CbGeAlD
Afatinib—ABCG2—nephron tubule—type 1 diabetes mellitus	0.000658	0.0187	CbGeAlD
Afatinib—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000403	0.0115	CbGeAlD
Afatinib—Vandetanib—ALB—type 1 diabetes mellitus	0.000388	0.0461	CrCbGaD
Afatinib—Gefitinib—ALB—type 1 diabetes mellitus	0.000369	0.0438	CrCbGaD
Afatinib—ABCB1—retina—type 1 diabetes mellitus	0.000345	0.0098	CbGeAlD
Afatinib—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000325	0.00923	CbGeAlD
Afatinib—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000292	0.00829	CbGeAlD
Afatinib—ABCB1—kidney—type 1 diabetes mellitus	0.000285	0.00811	CbGeAlD
Afatinib—ABCB1—pancreas—type 1 diabetes mellitus	0.000283	0.00805	CbGeAlD
Afatinib—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000245	0.00696	CbGeAlD
Afatinib—ERBB2—Innate Immune System—IL6—type 1 diabetes mellitus	1.85e-05	7.3e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL1B—type 1 diabetes mellitus	1.84e-05	7.26e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—CD4—type 1 diabetes mellitus	1.84e-05	7.26e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL2—type 1 diabetes mellitus	1.84e-05	7.24e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—VAV1—type 1 diabetes mellitus	1.84e-05	7.23e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—TYK2—type 1 diabetes mellitus	1.83e-05	7.22e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—ERBB3—type 1 diabetes mellitus	1.83e-05	7.2e-05	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—IL6—type 1 diabetes mellitus	1.83e-05	7.19e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PRKCQ—type 1 diabetes mellitus	1.82e-05	7.17e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL1B—type 1 diabetes mellitus	1.82e-05	7.16e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—CD4—type 1 diabetes mellitus	1.82e-05	7.15e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.81e-05	7.13e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL2—type 1 diabetes mellitus	1.81e-05	7.13e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DQB1—type 1 diabetes mellitus	1.8e-05	7.09e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL2RA—type 1 diabetes mellitus	1.77e-05	6.98e-05	CbGpPWpGaD
Afatinib—LCK—Disease—VAV1—type 1 diabetes mellitus	1.77e-05	6.97e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.77e-05	6.96e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—TYK2—type 1 diabetes mellitus	1.77e-05	6.96e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.76e-05	6.92e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.76e-05	6.92e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-A—type 1 diabetes mellitus	1.75e-05	6.91e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL1B—type 1 diabetes mellitus	1.75e-05	6.88e-05	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—EGFR—type 1 diabetes mellitus	1.74e-05	6.87e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL2—type 1 diabetes mellitus	1.74e-05	6.86e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.74e-05	6.86e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DQB1—type 1 diabetes mellitus	1.74e-05	6.83e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD86—type 1 diabetes mellitus	1.73e-05	6.83e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.7e-05	6.71e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—STAT3—type 1 diabetes mellitus	1.7e-05	6.7e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD40LG—type 1 diabetes mellitus	1.7e-05	6.7e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	1.7e-05	6.69e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.69e-05	6.67e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.69e-05	6.67e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.69e-05	6.66e-05	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.69e-05	6.65e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.68e-05	6.63e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD8A—type 1 diabetes mellitus	1.68e-05	6.62e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.68e-05	6.6e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—CRP—type 1 diabetes mellitus	1.67e-05	6.59e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD86—type 1 diabetes mellitus	1.67e-05	6.58e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CD80—type 1 diabetes mellitus	1.67e-05	6.56e-05	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—IL6—type 1 diabetes mellitus	1.66e-05	6.56e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.66e-05	6.53e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CD4—type 1 diabetes mellitus	1.66e-05	6.53e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD40LG—type 1 diabetes mellitus	1.64e-05	6.45e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—IL2—type 1 diabetes mellitus	1.63e-05	6.43e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD8A—type 1 diabetes mellitus	1.62e-05	6.38e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-B—type 1 diabetes mellitus	1.62e-05	6.37e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-DRB1—type 1 diabetes mellitus	1.6e-05	6.31e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CD86—type 1 diabetes mellitus	1.6e-05	6.3e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—INS—type 1 diabetes mellitus	1.6e-05	6.29e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CD4—type 1 diabetes mellitus	1.6e-05	6.29e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—TYK2—type 1 diabetes mellitus	1.6e-05	6.29e-05	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD4—type 1 diabetes mellitus	1.59e-05	6.27e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.59e-05	6.26e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—INS—type 1 diabetes mellitus	1.57e-05	6.2e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—IL6—type 1 diabetes mellitus	1.57e-05	6.19e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—ERBB3—type 1 diabetes mellitus	1.56e-05	6.16e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-B—type 1 diabetes mellitus	1.56e-05	6.14e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—STAT3—type 1 diabetes mellitus	1.55e-05	6.09e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.55e-05	6.09e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—EGFR—type 1 diabetes mellitus	1.55e-05	6.09e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SST—type 1 diabetes mellitus	1.54e-05	6.08e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CD86—type 1 diabetes mellitus	1.54e-05	6.07e-05	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	1.54e-05	6.07e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.54e-05	6.05e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	1.54e-05	6.05e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD4—type 1 diabetes mellitus	1.53e-05	6.04e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—STAT3—type 1 diabetes mellitus	1.52e-05	6e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.52e-05	6e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL2RA—type 1 diabetes mellitus	1.52e-05	5.97e-05	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—IL6—type 1 diabetes mellitus	1.51e-05	5.97e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.51e-05	5.95e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—ERBB3—type 1 diabetes mellitus	1.51e-05	5.93e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-A—type 1 diabetes mellitus	1.5e-05	5.9e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IFNG—type 1 diabetes mellitus	1.5e-05	5.89e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.49e-05	5.85e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SST—type 1 diabetes mellitus	1.49e-05	5.85e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.48e-05	5.83e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD80—type 1 diabetes mellitus	1.48e-05	5.83e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TNF—type 1 diabetes mellitus	1.47e-05	5.8e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—STAT3—type 1 diabetes mellitus	1.47e-05	5.77e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.47e-05	5.77e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL2RA—type 1 diabetes mellitus	1.46e-05	5.75e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—STAT3—type 1 diabetes mellitus	1.45e-05	5.72e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD4—type 1 diabetes mellitus	1.44e-05	5.69e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-A—type 1 diabetes mellitus	1.44e-05	5.69e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—ERBB3—type 1 diabetes mellitus	1.44e-05	5.68e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CRP—type 1 diabetes mellitus	1.43e-05	5.63e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.43e-05	5.62e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—STAT3—type 1 diabetes mellitus	1.43e-05	5.62e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	1.43e-05	5.62e-05	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—IL6—type 1 diabetes mellitus	1.42e-05	5.6e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CCR5—type 1 diabetes mellitus	1.42e-05	5.59e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.41e-05	5.54e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—STAT3—type 1 diabetes mellitus	1.41e-05	5.54e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—EGFR—type 1 diabetes mellitus	1.41e-05	5.53e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.4e-05	5.52e-05	CbGpPWpGaD
Afatinib—LCK—Disease—ERBB3—type 1 diabetes mellitus	1.39e-05	5.48e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—EGFR—type 1 diabetes mellitus	1.38e-05	5.45e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—HLA-A—type 1 diabetes mellitus	1.38e-05	5.45e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.38e-05	5.44e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CRP—type 1 diabetes mellitus	1.38e-05	5.42e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GCG—type 1 diabetes mellitus	1.38e-05	5.41e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DRB1—type 1 diabetes mellitus	1.37e-05	5.39e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CCR5—type 1 diabetes mellitus	1.37e-05	5.39e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—EGFR—type 1 diabetes mellitus	1.37e-05	5.38e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	1.36e-05	5.35e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.34e-05	5.29e-05	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—IL6—type 1 diabetes mellitus	1.34e-05	5.28e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL1B—type 1 diabetes mellitus	1.33e-05	5.25e-05	CbGpPWpGaD
Afatinib—LCK—Disease—HLA-A—type 1 diabetes mellitus	1.33e-05	5.25e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—EGFR—type 1 diabetes mellitus	1.33e-05	5.24e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL2—type 1 diabetes mellitus	1.33e-05	5.23e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GCG—type 1 diabetes mellitus	1.33e-05	5.22e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.32e-05	5.21e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DRB1—type 1 diabetes mellitus	1.32e-05	5.2e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	1.3e-05	5.12e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—EGFR—type 1 diabetes mellitus	1.3e-05	5.11e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.29e-05	5.06e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.28e-05	5.05e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—EGFR—type 1 diabetes mellitus	1.28e-05	5.03e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.28e-05	5.02e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD80—type 1 diabetes mellitus	1.26e-05	4.98e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—type 1 diabetes mellitus	1.26e-05	4.95e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—TYK2—type 1 diabetes mellitus	1.25e-05	4.92e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.24e-05	4.88e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.24e-05	4.86e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.22e-05	4.82e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD80—type 1 diabetes mellitus	1.22e-05	4.8e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS2—type 1 diabetes mellitus	1.2e-05	4.74e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.19e-05	4.69e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL2—type 1 diabetes mellitus	1.19e-05	4.68e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—IL6—type 1 diabetes mellitus	1.19e-05	4.68e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.17e-05	4.62e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL2—type 1 diabetes mellitus	1.17e-05	4.61e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IFNG—type 1 diabetes mellitus	1.17e-05	4.61e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.17e-05	4.6e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CD80—type 1 diabetes mellitus	1.17e-05	4.6e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.16e-05	4.58e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NOS2—type 1 diabetes mellitus	1.16e-05	4.57e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—INS—type 1 diabetes mellitus	1.16e-05	4.55e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	1.13e-05	4.47e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD4—type 1 diabetes mellitus	1.13e-05	4.45e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CD80—type 1 diabetes mellitus	1.13e-05	4.43e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—EGFR—type 1 diabetes mellitus	1.12e-05	4.43e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.12e-05	4.42e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CD86—type 1 diabetes mellitus	1.12e-05	4.41e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—STAT3—type 1 diabetes mellitus	1.12e-05	4.4e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.12e-05	4.4e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—INS—type 1 diabetes mellitus	1.1e-05	4.35e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CD86—type 1 diabetes mellitus	1.08e-05	4.25e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL6—type 1 diabetes mellitus	1.08e-05	4.25e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—EGFR—type 1 diabetes mellitus	1.08e-05	4.25e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—TYK2—type 1 diabetes mellitus	1.07e-05	4.2e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.07e-05	4.2e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL6—type 1 diabetes mellitus	1.06e-05	4.19e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.06e-05	4.19e-05	CbGpPWpGaD
Afatinib—LCK—Disease—INS—type 1 diabetes mellitus	1.06e-05	4.19e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.06e-05	4.18e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—IL6—type 1 diabetes mellitus	1.05e-05	4.13e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL1B—type 1 diabetes mellitus	1.04e-05	4.11e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.04e-05	4.1e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL2—type 1 diabetes mellitus	1.04e-05	4.09e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.03e-05	4.07e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—TYK2—type 1 diabetes mellitus	1.03e-05	4.05e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.03e-05	4.04e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL6—type 1 diabetes mellitus	1.02e-05	4.03e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—EGFR—type 1 diabetes mellitus	1.02e-05	4e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—IL6—type 1 diabetes mellitus	1.02e-05	4e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.01e-05	3.99e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.01e-05	3.98e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1e-05	3.94e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IFNG—type 1 diabetes mellitus	1e-05	3.94e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—IL6—type 1 diabetes mellitus	9.97e-06	3.93e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.94e-06	3.91e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—TYK2—type 1 diabetes mellitus	9.86e-06	3.88e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.85e-06	3.88e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—IL6—type 1 diabetes mellitus	9.82e-06	3.87e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.8e-06	3.86e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.74e-06	3.84e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.72e-06	3.83e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS3—type 1 diabetes mellitus	9.68e-06	3.81e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD4—type 1 diabetes mellitus	9.66e-06	3.8e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IFNG—type 1 diabetes mellitus	9.63e-06	3.79e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.58e-06	3.77e-05	CbGpPWpGaD
Afatinib—LCK—Disease—TYK2—type 1 diabetes mellitus	9.5e-06	3.74e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.44e-06	3.72e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NOS3—type 1 diabetes mellitus	9.32e-06	3.67e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD4—type 1 diabetes mellitus	9.31e-06	3.66e-05	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	9.13e-06	3.6e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.09e-06	3.58e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—IL6—type 1 diabetes mellitus	8.97e-06	3.53e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.95e-06	3.52e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL1B—type 1 diabetes mellitus	8.92e-06	3.51e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CD4—type 1 diabetes mellitus	8.91e-06	3.51e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL2—type 1 diabetes mellitus	8.88e-06	3.5e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—STAT3—type 1 diabetes mellitus	8.75e-06	3.45e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—IL6—type 1 diabetes mellitus	8.64e-06	3.4e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—INS—type 1 diabetes mellitus	8.63e-06	3.4e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.6e-06	3.39e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL1B—type 1 diabetes mellitus	8.59e-06	3.38e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CD4—type 1 diabetes mellitus	8.59e-06	3.38e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL2—type 1 diabetes mellitus	8.59e-06	3.38e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL2—type 1 diabetes mellitus	8.56e-06	3.37e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	8.3e-06	3.27e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CD80—type 1 diabetes mellitus	8.18e-06	3.22e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—EGFR—type 1 diabetes mellitus	7.95e-06	3.13e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	7.91e-06	3.11e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CD80—type 1 diabetes mellitus	7.88e-06	3.1e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL6—type 1 diabetes mellitus	7.81e-06	3.08e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—INS—type 1 diabetes mellitus	7.73e-06	3.04e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	7.57e-06	2.98e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—STAT3—type 1 diabetes mellitus	7.48e-06	2.94e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.47e-06	2.94e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—INS—type 1 diabetes mellitus	7.45e-06	2.93e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.23e-06	2.85e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—STAT3—type 1 diabetes mellitus	7.2e-06	2.84e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.2e-06	2.84e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	7.03e-06	2.77e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL6—type 1 diabetes mellitus	6.98e-06	2.75e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.9e-06	2.72e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—STAT3—type 1 diabetes mellitus	6.9e-06	2.72e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL6—type 1 diabetes mellitus	6.88e-06	2.71e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.78e-06	2.67e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.65e-06	2.62e-05	CbGpPWpGaD
Afatinib—LCK—Disease—STAT3—type 1 diabetes mellitus	6.65e-06	2.62e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.57e-06	2.59e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—EGFR—type 1 diabetes mellitus	6.55e-06	2.58e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.53e-06	2.57e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6—type 1 diabetes mellitus	6.11e-06	2.41e-05	CbGpPWpGaD
Afatinib—LCK—Disease—EGFR—type 1 diabetes mellitus	6.05e-06	2.38e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.75e-06	2.27e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2—type 1 diabetes mellitus	5.74e-06	2.26e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.72e-06	2.25e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.54e-06	2.18e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2—type 1 diabetes mellitus	5.54e-06	2.18e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6—type 1 diabetes mellitus	5.22e-06	2.06e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.05e-06	1.99e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6—type 1 diabetes mellitus	5.03e-06	1.98e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.83e-06	1.9e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6—type 1 diabetes mellitus	4.82e-06	1.9e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—INS—type 1 diabetes mellitus	4.66e-06	1.84e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.66e-06	1.83e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6—type 1 diabetes mellitus	4.65e-06	1.83e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	4.28e-06	1.68e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.23e-06	1.67e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	4.09e-06	1.61e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6—type 1 diabetes mellitus	3.38e-06	1.33e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6—type 1 diabetes mellitus	3.25e-06	1.28e-05	CbGpPWpGaD
